Evidence map›Paper›PMID 41574717›Full record

ReviewOncology reports2026

Recapitulating lung cancer metastasis

Jian Jiang, Guomin Dong, Zhiyun Zhang, Xiaoyuan Lei, Fanshu Huang, Suoni Li, Jiequn Ma, Jie Bai, Qian Ge, Hui Wei and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jian JiangGraduate School, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China.
Guomin DongGraduate School, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China.
Zhiyun ZhangGraduate School, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China.
Xiaoyuan LeiGraduate School, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China.
Fanshu HuangGraduate School, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China.
Suoni LiDepartment of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710061, P.R. China.
Jiequn MaDepartment of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710061, P.R. China.
Jie BaiDepartment of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710061, P.R. China.
Qian GeGraduate School, Xi'an Medical University, Xi'an, Shaanxi 710000, P.R. China.
Hui WeiDepartment of Oncology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China.
Zheng ZhaoDepartment of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710061, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains a significant global health challenge, with metastatic progression being the leading driver of mortality. Organoid technology provides a tractable, physiologically relevant platform to model key aspects of lung cancer metastasis

Indexed as

Lung NeoplasmsOrganoidsAnimalsHumansModels, BiologicalNeoplasm MetastasisPrecision MedicineTranslational Research, BiomedicalTumor Microenvironmentlung cancermetastasis modelorganoidsprecision medicinetumor heterogeneitytumor microenvironment

Identifiers

PMID41574717
PMCPMC12854103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.